Full Press Release Details
SHANGHAI & CAMBRIDGE, Mass.–(BUSINESS WIRE)–May 16, 2024– Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024:
J.P. Morgan 20th Annual Global China SummitPanel Discussion: Thursday, May 23, 2024, 10:00 a.m. HKT Location: Shanghai, China
Jefferies Global Healthcare ConferenceFireside Chat: Wednesday, June 5, 2024, 3:30 p.m. ET in Track 2 Location: New York, New York
Goldman Sachs 45th Annual Global Healthcare Conference Presentation: Wednesday, June 12, 2024, 1:20 p.m. ETLocation: Miami Beach, Florida
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.
For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240516389098/en/
Investor Relations: Christine Chiou / Lina Zhang+1 (917) 886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen+1 (415) 317-7255 / +86 185 0015 5011 shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com
Source: Zai Lab Limited